Financial Information Show all 2021 Q3 Syndax Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Business Update Proxy Statements Filing date View 04.01.21 View HTML 0001564590-21-017347.pdf 0001564590-21-017347.xls Form 10-K Filing date View 03.12.21 View HTML 0001564590-21-012607.pdf 0001564590-21-012607.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA Form 10-Q Filing date View 11.15.21 View HTML 0001564590-21-057004.pdf 0001564590-21-057004.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA 08.09.21 View HTML 0001564590-21-042657.pdf 0001564590-21-042657.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
